15.2 C
New York
Tuesday, April 16, 2024

Viking’s obesity drug study results are ‘almost flawless’, says Oppenheimer’s Jay Olson

Jay Olson, Oppenheimer biotech analyst, joins ‘Fast Money’ to talk Viking’s best trading day ever and the results of its obesity drug study.

This post was originally published on this site

Subscribe
Notify of
0 Comments
Inline Feedbacks
View all comments

Stay Connected

157,379FansLike
396,312FollowersFollow
2,290SubscribersSubscribe

Latest Articles

0
Would love your thoughts, please comment.x
()
x